These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 19709755)

  • 1. Canine CD8 T cells showing NK cytotoxic activity express mRNAs for NK cell-associated surface molecules.
    Lin YC; Huang YC; Wang YS; Juang RH; Liao KW; Chu RM
    Vet Immunol Immunopathol; 2010 Feb; 133(2-4):144-53. PubMed ID: 19709755
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD5-low expression lymphocytes in canine peripheral blood show characteristics of natural killer cells.
    Huang YC; Hung SW; Jan TR; Liao KW; Cheng CH; Wang YS; Chu RM
    J Leukoc Biol; 2008 Dec; 84(6):1501-10. PubMed ID: 18708592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T-EMRA lymphocytes.
    Franceschetti M; Pievani A; Borleri G; Vago L; Fleischhauer K; Golay J; Introna M
    Exp Hematol; 2009 May; 37(5):616-628.e2. PubMed ID: 19375652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study of intralymphatic interleukin-2. I. Cytotoxic and surface marker changes of peripheral blood lymphocytes.
    Shau H; Isacescu V; Ibayashi Y; Tokuda Y; Golub SH; Fahey JL; Sarna GP
    J Biol Response Mod; 1990 Feb; 9(1):71-80. PubMed ID: 2319261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysis of tumor cells by CD3+4-8-16+ T cell receptor alpha beta- clones, regulated via CD3 and CD16 activation sites, recombinant interleukin 2, and interferon beta 1.
    van de Griend RJ; Tax WJ; van Krimpen BA; Vreugdenhil RJ; Ronteltap CP; Bolhuis RL
    J Immunol; 1987 Mar; 138(5):1627-33. PubMed ID: 2949018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perforin expression can define CD8 positive lymphocyte subsets in pigs allowing phenotypic and functional analysis of natural killer, cytotoxic T, natural killer T and MHC un-restricted cytotoxic T-cells.
    Denyer MS; Wileman TE; Stirling CM; Zuber B; Takamatsu HH
    Vet Immunol Immunopathol; 2006 Apr; 110(3-4):279-92. PubMed ID: 16325923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel functional cell surface dimer (Kp43) expressed by natural killer cells and T cell receptor-gamma/delta+ T lymphocytes. I. Inhibition of the IL-2-dependent proliferation by anti-Kp43 monoclonal antibody.
    Aramburu J; Balboa MA; Ramírez A; Silva A; Acevedo A; Sánchez-Madrid F; De Landázuri MO; López-Botet M
    J Immunol; 1990 Apr; 144(8):3238-47. PubMed ID: 1691231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphokine-activated killer cells. VII. IL-4 induces an NK1.1+CD8 alpha+beta- TCR-alpha beta B220+ lymphokine-activated killer subset.
    Ballas ZK; Rasmussen W
    J Immunol; 1993 Jan; 150(1):17-30. PubMed ID: 7678028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of rat T cell subpopulations expressing T cell receptors alpha/beta and gamma/delta.
    Lawetzky A; Tiefenthaler G; Kubo R; Hünig T
    Eur J Immunol; 1990 Feb; 20(2):343-9. PubMed ID: 2138084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mistletoe lectin I-induced effects on human cytotoxic lymphocytes. I. Synergism with IL-2 in the induction of enhanced LAK cytotoxicity.
    Baxevanis CN; Voutsas IF; Soler MH; Gritzapis AD; Tsitsilonis OE; Stoeva S; Voelter W; Arsenis P; Papamichail M
    Immunopharmacol Immunotoxicol; 1998 Aug; 20(3):355-72. PubMed ID: 9736441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TCR alpha beta+ anti-tumor cytolytic T lymphocytes express NKR-P1 whilethe anti-tumor activity of TCR gamma delta+ T lymphocytes is not correlated to NKR-P1 expression.
    Yrlid U; Petersson E; Dohlsten M; Hedlund G
    Cell Immunol; 1996 Nov; 173(2):287-94. PubMed ID: 8912889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes.
    Lanier LL; Le AM; Civin CI; Loken MR; Phillips JH
    J Immunol; 1986 Jun; 136(12):4480-6. PubMed ID: 3086432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of a cell line, NKL, derived from an aggressive human natural killer cell leukemia.
    Robertson MJ; Cochran KJ; Cameron C; Le JM; Tantravahi R; Ritz J
    Exp Hematol; 1996 Feb; 24(3):406-15. PubMed ID: 8599969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of IL-4 in proliferation and differentiation of human natural killer cells. Study of an IL-4-dependent versus an IL-2-dependent natural killer cell clone.
    Hayakawa K; Salmeron MA; Kornbluth J; Bucana C; Itoh K
    J Immunol; 1991 Apr; 146(7):2453-60. PubMed ID: 1900882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular studies on LAK cells.
    Fagioli M; Carè A; Ciccone E; Moretta L; Moretta A; Testa U; Falini B; Grignani F; Peschle C; Pelicci PG
    Ann Ist Super Sanita; 1990; 26(3-4):357-68. PubMed ID: 1982603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell clones expressing the natural killer cell-related p58 receptor molecule display heterogeneity in phenotypic properties and p58 function.
    Ferrini S; Cambiaggi A; Meazza R; Sforzini S; Marciano S; Mingari MC; Moretta L
    Eur J Immunol; 1994 Oct; 24(10):2294-8. PubMed ID: 7925558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+ T lymphocytes, and NK cells.
    Perussia B; Chan SH; D'Andrea A; Tsuji K; Santoli D; Pospisil M; Young D; Wolf SF; Trinchieri G
    J Immunol; 1992 Dec; 149(11):3495-502. PubMed ID: 1358972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human lymphokine-activated killer (LAK) cells: identification of two types of effector cells.
    Tilden AB; Itoh K; Balch CM
    J Immunol; 1987 Feb; 138(4):1068-73. PubMed ID: 3100627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T; Belfrage H; Bhiladvala P; Hedlund G
    J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.